MedTrace Logo

Evaluation of a Gamified Electronic Medication Administration Record (eMAR) System

NCT03219151 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2018-06-25

No results posted yet for this study

Summary

This research project will evaluate a gamified electronic medication administration record (eMAR) system simulator as a mechanism to improve students' learning of medication administration in simulated clinical education. The gamified eMAR simulator will be evaluated using a pragmatic randomized controlled trial design in order to determine the effectiveness of the game as a technology-enabled, online learning intervention.

Conditions

  • Nurse's Role
  • Medication Administered in Error
  • Simulation of Physical Illness

Interventions

DEVICE

eMAR game

The eMAR simulator videogame affords students a virtual and immersive opportunity to practice medication administration using an eMAR system, in a structured fashion that provides real-time feedback related to best-practices and safety compliance of the medication process

OTHER

Normal pre-work

Participants complete normal education pre-work related to eMAR administration, in advance of simulated return-demonstration

Sponsors & Collaborators

  • eCampusOntario

    collaborator UNKNOWN

  • Centre for Addiction and Mental Health

    collaborator OTHER

  • Texas Tech University Health Sciences Center

    collaborator OTHER

  • London Health Sciences Centre

    collaborator OTHER

  • St. Joseph's Health Care London

    collaborator OTHER

  • Wilfrid Laurier University

    collaborator OTHER

  • Western University, Canada

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-29
Primary Completion
2018-03-31
Completion
2018-04-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03219151 on ClinicalTrials.gov